Pharmacogenomics

Assessing performance of prediction rules in machine learning
pp. 543-550(8)
Authors: Martin, Rory; Yu, Kai

ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients
pp. 551-561(11)
Authors: Seo, Takayuki; Ishitsu, Takateru; Ueda, Nao; Nakada, Naoyuki; Yurube, Keigo; Ueda, Kentaro; Nakagawa, Kazuko

Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients
pp. 563-574(12)
Authors: Cheung, Chi Yuen; Op den Buijsch, Robert AM; Ming Wong, Kim; Wong Chan, Hoi; Foon Chau, Ka; Sang Li, Chun; Tai Leung, Kay; Hoi Kwan, Tze; de Vrie, Johan E; Wijnen, Petal AHM; van Dieijen-Visser, Marja P; Bekers, Otto

Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8
pp. 575-585(11)
Authors: García-Martín, Elena; Pizarro, Rosa M; Martínez, Carmen; Gutierrez-Martín, Yolanda; Pérez, Gabriela; Jover, Ramiro; Agúndez, José AG

The clinical implications of antiretroviral pharmacogenomics
pp. 587-596(10)
Authors: Fox, Julie; Boffito, Marta; Winston, Alan

High-throughput mutational analysis of the human cancer genome
pp. 597-612(16)
Authors: Ma, Patrick C; Zhang, Xiaodong; Wang, Zhenghe J

The role of genetic variability in drug metabolism pathways in breast cancer prognosis
pp. 613-624(12)
Authors: Choi, Ji-Yeob; Nowell, Susan A; Blanco, Javier G; Ambrosone, Christine B

Global pharmacogenetics: giving the genome to the masses
pp. 625-631(7)
Authors: Marsh, Sharon; Van Booven, Derek J; McLeod, Howard L

EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions
pp. 633-638(6)
Authors: Molokhia, Mariam; McKeigue, Paul

Whole-genome genotyping of haplotype tag single nucleotide polymorphisms
pp. 641-648(8)
Authors: Gunderson, Kevin L; Kuhn, Kenneth M; Steemers, Frank J; Ng, Pauline; Murray, Sarah S; Shen, Richard